Research Scientist II
Sean Moran is a neuropharmacologist with a strong passion for translational neuroscience research who earned his PhD from Vanderbilt University under the mentorship of P. Jeffrey Conn. During his graduate training at the Vanderbilt Center for Neuroscience Drug Discovery, Sean utilized molecular pharmacology, brain slice electrophysiology and rodent behavior to better understand the diverse pharmacological properties of structurally distinct allosteric modulators of muscarinic acetylcholine and metabotropic glutamate receptors and their potential as novel treatments for neurological disorders. Currently, Sean is investigating the role of Cav3.3 (a T-type voltage gated calcium channel) in learning and memory in order to better characterize the potential of Cav3.3 as a therapeutic target for the cognitive disruptions in patients with schizophrenia. Outside of lab, Sean enjoys cycling, brewing coffee, sharing good food and wine with friends and the occasional terrible pun.